Back HIV Treatment Search for a Cure

Search for a Cure

International AIDS Society Conference Starts Sunday

The 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) will kick of Sunday, June 30, in Kuala Lumpur Malaysia. Key areas of interest will include new developments in antiretroviral therapy, biomedical HIV prevention, and improving access to and retention in care.alt

Read more:

30 Years of HIV: Long Road Ahead to a Cure

Scientists from around the world met to review the future of HIV scientific research at the Institut Pasteur in Paris, last month -- 30 years after the discovery of HIV by a team based at the institute. The prospects for a cure for HIV infection were a major theme of the meeting, which attracted around 500 scientists, chiefly from France and the United States.

alt

Read more:

Sangamo Reports Zinc Finger Gene Therapy Leads to Long-term CD4 Cell Gains, Shrinking HIV Reservoirs

An experimental gene therapy technique that modifies CD4 T-cells to protect them from viral entry produced lasting CD4 cell increases with a single infusion, as well as reduction in proviral DNA reservoirs and decreased viral load in 2 patients who underwent antiretroviral therapy (ART) interruption, according to data presented this week at the 16th Annual Meeting of the American Society of Gene and Cell Therapy in Salt Lake City.

alt

Read more:

FDA to Hold Public Meeting on Patient-Focused Drug Development and HIV Cure Research

On June 14, the U.S. Food and Drug Administration (FDA) will host a public meeting on patient-focused HIV drug development and cure-related research at its Maryland headquarters, the agency announced this month. Participants are requested to register by June 5.alt

Read more:

Very Early Antiretroviral Therapy Does Not Prevent Immune Activation

People who started antiretroviral therapy (ART) during acute HIV infection and experienced sustained viral suppression saw a substantial decrease in immune activation markers on their CD8 T-cells after 2 years of treatment, but often not to the level seen in HIV negative individuals, according to a report in the April 15, 2013, Journal of Acquired Immune Deficiency Syndromes.

alt

Read more: